Agranulocytosis and Systemic lupus erythematosus


Systemic lupus erythematosus is found among people with Agranulocytosis, especially for people who are female, 30-39 old.

The study analyzes which people have Systemic lupus erythematosus with Agranulocytosis. It is created by eHealthMe based on reports of 10 people who have Agranulocytosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 30, 2022

10 people who have Agranulocytosis and Systemic Lupus Erythematosus are studied.

What is Agranulocytosis?

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection) is found to be associated with 3,053 drugs and 3,302 conditions by eHealthMe.

What is Systemic lupus erythematosus?

Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue) is found to be associated with 2,094 drugs and 1,449 conditions by eHealthMe.

Number of Systemic lupus erythematosus in Agranulocytosis reports submitted per year:

Would you have Systemic lupus erythematosus when you have Agranulocytosis?

Gender of people who have Agranulocytosis and experienced Systemic Lupus Erythematosus *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Agranulocytosis and experienced Systemic Lupus Erythematosus *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 10 %
  • 20-29: 40 %
  • 30-39: 40 %
  • 40-49: 0.0 %
  • 50-59: 10 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Urinary Tract Infection: 1 person, 10.00%
  2. Ovarian Disorder (disease of ovary): 1 person, 10.00%
  3. Leukopenia (less number of white blood cells in blood): 1 person, 10.00%
  4. Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 1 person, 10.00%
  5. Bone Marrow Failure: 1 person, 10.00%
  6. Bladder Disorder: 1 person, 10.00%

Common drugs taken by these people *:

  1. Prednisolone: 4 people, 40.00%
  2. Neupogen: 4 people, 40.00%
  3. Tacrolimus: 3 people, 30.00%
  4. Micafungin: 3 people, 30.00%
  5. Mycophenolate Mofetil: 2 people, 20.00%
  6. Methotrexate: 1 person, 10.00%
  7. Humira: 1 person, 10.00%
  8. Cyclophosphamide: 1 person, 10.00%

Common symptoms for these people *:

  1. Febrile Neutropenia (fever with reduced white blood cells): 4 people, 40.00%
  2. Acute Kidney Failure: 2 people, 20.00%
  3. Fever: 2 people, 20.00%
  4. Pulmonary Aspergilloma (Mycetoma) (mass caused by a fungal infection that usually grows in lung): 2 people, 20.00%
  5. Vitamin B12 Deficiency: 1 person, 10.00%
  6. Drug Hypersensitivity: 1 person, 10.00%
  7. Hyperhidrosis (abnormally increased sweating): 1 person, 10.00%
  8. Hyperaesthesia: 1 person, 10.00%
  9. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 1 person, 10.00%
  10. Hair Loss: 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Systemic lupus erythematosus?

Check whether Systemic lupus erythematosus is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Systemic lupus erythematosus:

Common drugs associated with Systemic lupus erythematosus:

All the drugs that are associated with Systemic lupus erythematosus:

Common conditions associated with Systemic lupus erythematosus:

All the conditions that are associated with Systemic lupus erythematosus:

How the study uses the data?

The study is based on Systemic lupus erythematosus and Agranulocytosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: